Thyrocare Technologies added 2.70% to Rs 838.30 after the healthcare service provider reported 28.56% increase in consolidated net profit to Rs 18.95 crore on 23.14% rise in revenue from operations to ...

Indian Energy Exchange Q3 Results 2025 show a revenue increase of 14.53% YoY and a profit increase of 16.86% YoY, with profit ...

The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...

Shriram Finance is expected to post an 18 percent year-on-year (YoY) growth in loans for Q3FY25, with sequential growth ...

At around 10:21 am, shares of Cyient were down 17.96% to Rs 1,438 on the Bombay Stock Exchange (BSE). In early trade, shares ...

Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, ...

IST, the barometer index, the S&P BSE Sensex shed 26.18 points or 0.03% to 76,494.20. The Nifty 50 index lost 21.60 points or 0.09% to 23,183.75.

Shares of Dr Reddy's Laboratories Ltd tumbled more than 6.65 per cent to Rs 1,203.60 on Friday, with its total market capitalisation slipping below Rs 1 lakh crore mark.

Brokerage firm Citi maintained its "buy" rating on Indus Towers with a price target of ₹485, citing three key positives from the quarter, which included better tenancies, recovery of dues and a higher ...

UltraTech Cement shares rose 1% following strong Q3 results, with a 17% YoY profit decline but revenue exceeding estimates. Brokerages remain positive, with target prices ranging from Rs 12,100 to Rs ...